Watch the latest video from our Chief Executive Andrew Newland
Introducing the Parsortix®PC1 system - the first medical device to receive FDA clearance for the harvest of intact CTCs
Onc-ADaPT laboratories provide specialized circulating tumor cell (CTC) enrichment and analysis services
Circulating tumor cells (CTCs) have the potential to impact clinical decision making
Catch up with the latest webinars
Latest report
Please click the links below to download our Annual and Interim Reports and Financial Statements
For any investor relations queries please contact
World leaders in liquid biopsy, dedicated to improving cancer patient care
Employees share their experiences of working at ANGLE
Click on a vacancy to read more and to apply online
Hosted by subject matter experts
Management, Board of Directors and Scientific Advisory Board
Ask us how we can help with your liquid biopsy needs
Making a difference to future generations
CTC capture and harvest